Updates from The Motley Fool

Latest updates on Trinity Biotech plc (ADR) from Fool.com.


Stock Performance

TRIB vs. S&P 500 | 2 Year Performance
TRIB 1-Day Stock Chart
TRIB 5-Day Stock Chart
TRIB 1-Month Stock Chart
TRIB 3-Month Stock Chart
TRIB 6-Month Stock Chart
TRIB 1-Year Stock Chart
TRIB 2-Year Stock Chart
TRIB 5-Year Stock Chart
View Interactive TRIB Charts
Sponsored by

Key Data Points

Primary metrics and data points about Trinity Biotech plc (ADR).
Current Price: $10.97
Prev Close: $11.01
Open: $10.88
Bid: $10.94
Ask: $10.96
Day's Range: $10.80 - $11.18
52wk Range: $9.20 - $19.03
Volume: 34,990
Avg Vol 75,710
Market Cap: $258.64M
P/E (ttm): 26.21
EPS (ttm): $0.00
Div & Yield: $0.22 (2.0%)

Company Rating

What our community thinks about Trinity Biotech plc (ADR).
CAPS Rating 4 out of 5
 
140 Outperform
10 Underperform
CAPS All Stars
 
19 Outperform
1 Underperform

How do you think Trinity Biotech plc (ADR) will perform against the market?



You pick for Trinity Biotech plc (ADR) is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Ronan O'Caoimh, CEO

22% Approve

Based on 8 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Trinity Biotech plc (ADR).

The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers